The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Research interests
Neuro-ophthalmology Eye movements, Vision, Sensory Motor integration,
Marc trained in Paediatrics and Paediatric Infectious Diseases in the UK (Great Ormond Street Hospital, St Mary's Hospital London), Germany, South Africa (University of Cape Town) and Australia (University of New South Wales). After 4 years of research into improved immunodiagnostics for childhood tuberculosis at the University of Melbourne and the Royal Children's Hospital Melbourne, he returned to the UK in 2011 as NIHR Academic Clinical Lecturer in Paediatric Infectious Diseases & Immunology.
Dr. Vaisitti has been working in the field of CLL since she started her PhD program studying the role of CD38 in the biology and pathogenesis of CLL. She continued the training in hematology/oncology obtaining a 3-year fellowship from the Italian Association for Cancer Research (AIRC), with a project aimed at analysing and dissecting the molecular mechanisms regulating leukemic proliferation and homing. Dr. Vaisitti spent several periods in Italian and foreign laboratories as a visiting scientist including a period at Feinstein Institute for Medical Research, North Shore-Long Island Jewish (NY) and a period at the Dept. of Medical Biochemistry and Immunology, Cardiff University (UK). Recently, Dr. Vaisitti spent 2 years as a visiting fellow at the Weill Cornell Medical College, Dept. of Pathology and Laboratory Medicine (NY), to set up patient-derived xenograft models of CLL and Richter syndrome, and also investigate the functional impact of novel drugs.
In the last 5 years, Dr. Vaisitti’s research has been focused on two main topics. The first one is the functional analysis of genes found recurrently mutated in chronic lymphoproliferative syndromes. Attention has been focused on NOTCH1, SF3B1, BIRC3 and NOTCH2. These works were done in a joint collaboration with the group of Prof. Gaidano (University of Eastern Piedmont, Italy). The second topic is the discovery and analysis of host microenvironmental conditions that favor leukemic development and progression.
Prof. Cheryl S. Rosenfeld is a Professor of Biomedical Sciences at the University of Missouri Columbia. Prof. Rosenfeld specializes in studying the effects of maternal diet on offspring, exploring how the in-utero environment can shape risks for later disease. Her research with mice has yielded major breakthroughs. She has determined that an energy-rich maternal diet will result in more male mouse pups, while a restricted-calorie diet produces daughters more frequently. She also established a relationship between a certain hair-coat color and obesity and diabetes in mice. Most recently, the Rosenfeld lab has identified spatial learning disabilities in male deer mice whose mothers consumed a diet supplemented with bisphenol A, (BPA), a known endocrine disruptor and a common pollutant. This disability is expected to hinder the males in navigating to find mates; the finding has implications for deer mice populations exposed to BPA in the wild.
1995: Degree in Pharmaceutical Chemistry, University of Milan
1997: Degree in Pharmacology, University of Milan
2001: Ph.D. in Natural Sciences, University of Zürich
1999-2002: Research fellow at the Imperial College - School of Medicine at St. Mary’s, London
2002-2009: Senior scientist at the University of Milan
Since 2009: Head of the Laboratory for Research on Neurodegenerative Disorders, Fondazione
Salvatore Maugeri – Clinica del Lavoro e della Riabilitazione - IRCCS, Pavia
Reader in the Molecular Cell Sciences Research Centre, St Georges University London (SGUL). Studies DNA replication and chromatin structure mainly using Drosophila Melanogaster as a model system.
Dr. Johannie Spaan is a Postdoctoral Fellow at the College of Osteopathic Medicine of the Pacific Northwest (Western University of Health Sciences). Her research interests focus on stress physiology, disease ecology, eco-immunology and parasitology.
More specifically, Dr. Spaan's research within the Steinauer lab is focused on a neglected tropical disease, Schistosomiasis, a helminth infection that affects over 200 million people. Research carried out within the lab focuses on uncovering potential mechanisms that can be manipulated to break the life cycle of this pathogen in order to reduce or eliminate schistosome transmission to humans.
In addition to this, Dr. Spaan is also involved in a project investigating the effect of schistosome infections in a mouse model system and the links among parasite infection, behavioral and cognitive changes, microbiome alteration, and systemic inflammation.
Brenton Graveley is Associate Director of the University of Connecticut Institute for Systems Genomics and the John and Donna Krenicki Professor of Genomics and Personalized Healthcare in the Department of Genetics and Genome Sciences at UConn Health in Farmington, CT. Brent has studied RNA biology throughout his entire career. He performed his undergraduate studies at the University of Colorado, Boulder with David Prescott, his graduate studies at the University of Vermont with Greg Gilmartin, and his postdoctoral studies at Harvard University with Tom Maniatis. Brent has led large components of the ENCODE and modENCODE projects, studies the mechanisms of alternative splicing using genomic, genetic, and biochemical approaches, and collaborates extensively to investigate various aspects of RNA biology.
Dr. Carla Minoia is a MD at IRCCS Istituto Tumori "Giovanni Paolo II" Bari (Italy). Her PhD involved clinical research on lymphoma, survivorship, and quality of life.
Providing translational genomics + bioinformatics solutions for Next Generation Sequencing (NGS) big-data applications and interpretation of human variation for functional genomics and precision medicine.
Dr. Toryn Poolman is a Lecturer in the Department of Structural & Molecular Biology at University College London.
His primary research interests include applying omics techniques, including RNAseq, phospho-proteomics, and microbiome analysis.
Clinical epidemiologist, biostatistician and research methodologist with special interests in study design and methods, clinical research, and evidence synthesis (by means of systematic reviews, classic and network meta-analyses) to inform health care decisions.
Associate Professor at Humanitas University, Milan, Italy.